Prefrontal cortex lesions and MAO-A modulate aggression in penetrating traumatic brain injury

M Pardini1, F Krueger, C Hodgkinson

  • 1Cognitive Neuroscience Section, National Institute of Neurological Disorders and Stroke-NIH, Bethesda, MD, USA.

Neurology
|March 23, 2011
PubMed
Abstract

Insights

Brain lesion location and MAO-A genotype interact to influence aggression in penetrating traumatic brain injury (PTBI). Prefrontal cortex integrity is key for modulating aggression related to genetics and trauma.

Area of Science:

  • Neuroscience
  • Genetics
  • Trauma Research

Background:

  • Penetrating traumatic brain injury (PTBI) can lead to aggression.
  • The role of genetic factors, like monoamine oxidase A (MAO-A) polymorphism, in aggression post-PTBI is not fully understood.
  • Brain lesion location may influence the expression of genetic predispositions for aggression.

Purpose of the Study:

  • To investigate the interaction between MAO-A genotype and lesion location in the development of aggression in PTBI patients.
  • To determine if prefrontal cortex (PFC) integrity affects the relationship between MAO-A, trauma, and aggression.

Main Methods:

  • 155 PTBI patients and 42 controls from the Vietnam Head Injury Study were analyzed.
  • PTBI patients were categorized by lesion location (PFC vs. non-PFC).
  • MAO-A genotype (low vs. high transcriptional activity) and aggression (Neuropsychiatric Inventory aggression subscale) were assessed.

Main Results:

  • Aggression was higher in PTBI patients with PFC lesions.
  • A significant interaction was found between MAO-A activity and lesion location impacting aggression.
  • In non-PFC lesions, high MAO-A activity correlated with higher aggression, unlike in PFC lesions.

Conclusions:

  • Lesion location and MAO-A genotype interact to mediate aggression in PTBI.
  • PFC integrity is crucial for modulating aggression influenced by genetic and experiential factors.
  • Combining lesion and genotype data may enable risk stratification and personalized treatments for PTBI-related aggression.